RevelAi Health
Dan Wu, MBA, MSE, is an accomplished Chief Product Officer currently leading RevelAi Health, a provider workflow automation platform focused on patient engagement and analytics. As a co-founder and Chief Product Officer at Palisaid, Dan specializes in developing automated solutions for chronic care management. Previously, Dan held senior leadership roles at Best Buy Health as Senior Director of Product Management and served as a Product Management Consultant for several HealthTech startups. Additional experience includes significant contributions at Clinicient as VP of Product and SC Johnson as Senior Director of Product Management. Dan's early career accomplishments include impactful roles at Intellectual Ventures and Philips Medical Systems, where innovations in technology management and product development were achieved. Educational qualifications include an MBA and an MSE from the University of Washington, alongside a Bachelor of Science in Engineering from Zhejiang University.
This person is not in any teams
RevelAi Health
RevelAi Health (formerly Azra Care) is an equity-conscious SaaS AI company that champions the transition to Value-Based Care (VBC) in Specialty Care, focusing on orthopaedic surgery and musculoskeletal health. RevelAi Health is guided by physicians and community leaders committed to shifting the current paradigm of healthcare to improve outcomes for patients while combating clinician burnout. Our expert-curated Large Language Model powers an AI-driven care navigation and intelligent clinical workflow automation tailored to relieve provider workload while fostering enhanced patient-provider relationships. These novel methods optimize productivity and enable healthcare providers to meet and exceed VBC metric benchmarks, all while ensuring that care is delivered equitably. As a conduit for bridging the data, analytics, and technology infrastructure gaps, RevelAi Health transforms data on health-related social needs into actionable solutions catering to our most vulnerable and high-cost elderly patients.